Tyra Biosciences, Inc. (TYRA): Price and Financial Metrics
TYRA Price/Volume Stats
| Current price | $10.32 | 52-week high | $29.60 |
| Prev. close | $10.91 | 52-week low | $6.42 |
| Day low | $10.20 | Volume | 53,132 |
| Day high | $11.00 | Avg. volume | 323,066 |
| 50-day MA | $9.89 | Dividend yield | N/A |
| 200-day MA | $13.61 | Market Cap | 547.89M |
TYRA Stock Price Chart Interactive Chart >
Tyra Biosciences, Inc. (TYRA) Company Bio
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
TYRA Price Returns
| 1-mo | -1.05% |
| 3-mo | 19.86% |
| 6-mo | -36.10% |
| 1-year | -48.58% |
| 3-year | 6.94% |
| 5-year | N/A |
| YTD | -25.76% |
| 2024 | 0.36% |
| 2023 | 82.24% |
| 2022 | -45.98% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...